BioAscent

United Kingdom
Newhouse, North Lanarkshire, United Kingdom

Company profile

BioAscent company profile

BioAscent, based at the former Organon / MSD R&D site in Newhouse, Scotland, UK, is a leading provider of integrated drug discovery services, including de novo assay development, target analysis and bespoke screening strategies, compound screening (including HTS), medicinal and synthetic chemistry, computational chemistry, and compound management, all with access to in-house diversity and fragment libraries.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2013-01-01, Year

Headquarters

Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Total equity funding
$2.1M
Last funding
Series Unknown / $2.1M / 2018-07-17
Last equity funding
Series Unknown / $2.1M
Investors
1
Lead investors
1
Founders
1
Articles
16

Founders and investors

Founders

Sylviane Boucharens

Lead investors

Maven Capital Partners

Investors

Maven Capital Partners